17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells
<p>Abstract</p> <p>Background</p> <p>17-Allylamino-17-demethoxygeldanamycin (17-AAG), a benzoquinone ansamycin antibiotic, specifically targets heat shock protein 90 (Hsp90) and interferes with its function as a molecular chaperone that maintains the structural and func...
Main Authors: | Karkoulis Panagiotis K, Stravopodis Dimitrios J, Margaritis Lukas H, Voutsinas Gerassimos E |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-09-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/481 |
Similar Items
-
Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin inhibits the proliferation of ARPE-19 cells
by: Wang Lin, et al.
Published: (2010-04-01) -
Pre-clinical and clinical evaluation of the heat shock protein 90 (HSP90) inhibitor 17-allylamino, 17-demethoxygeldanamycin (17-AAG)
by: Banerji, Udai
Published: (2005) -
The effect of 17-allylamino-17-demethoxygeldanamycin on enterovirus 71 replication in vitro and in vivo
by: Shih-YingWu, et al.
Published: (2012) -
Exploration of novel therapies for thyroid cancer: adenoviral gene therapy and 17-allylamino-17-demethoxygeldanamycin
by: Marsee, Derek K.
Published: (2004) -
Synergistic effect of 17-allylamino-17-demethoxygeldanamycin with dehydroxymethylepoxyquinomicin on the human anaplastic thyroid carcinoma cell line KTC2
by: Todorović Lidija, et al.
Published: (2021-01-01)